The Food and Drug Administration on Feb. 15 will publish a final rule to reclassify Medical Device Data Systems from Class III devices requiring premarket approval to Class I devices regulated under much less stringent general controls.

FDA is exempting such devices from premarket approval “on its own initiative,” and clearly defines the differences between the devices and patient monitoring devices that will remain heavily regulated:

Register or login for access to this item and much more

All Health Data Management content is archived after seven days.

Community members receive:
  • All recent and archived articles
  • Conference offers and updates
  • A full menu of enewsletter options
  • Web seminars, white papers, ebooks

Don't have an account? Register for Free Unlimited Access